Globally unique MRI Guarantee: outstanding MRI safety* with hearing implants from MED-EL

Feb 2, 2021

Worry-free magnetic resonance imaging (MRI) with MED-EL cochlear or bone conduction implants – now with lifetime guarantee! For immediate access to an MRI examination without surgery,1 discomfort or hearing downtime.

February 02, 2021- (Innsbruck, Austria) – MED-EL, the global innovation leader in hearing solutions, has announced a lifetime MRI Guarantee for users of their hearing implants. The company is currently the only manufacturer to accept liability for damage to their cochlear implants produced since 1994, and all MED-EL bone conduction implants during an MRI examination.2 Users of these MED-EL implants can therefore not only undergo an MRI examination at any time without the need for surgical removal of the magnets1 – they can also do so safely and with no worries.  

Three in four people will require an MRI scan in the next ten years.3 Whether routine or in an emergency: patients with severe hearing loss may face a challenge if the magnets in their hearing implants are not safe inside the MRI machine. This requires the prior surgical removal of the magnets. Hearing ability is temporarily lost and long-term damage to the implant may occur. If the patient declines surgery, they may suffer from severe pain during the examination coupled with the possible dislocation of the magnet.

Outstanding MRI safety with MED-EL

Not all implants carry this risk. As a leading manufacturer of implantable hearing solutions, MED-EL has for more than twenty years made a point of only producing implants that offer outstanding MRI safety. To emphasize this requirement, MED-EL offers a unique MRI Guarantee which provides a promise to replace the implant in the very unlikely event that it is damaged during an MRI scan.MED-EL is thereby the only manufacturer to issue its users with a global lifetime MRI guarantee. . 

“The MRI Guarantee ensures more safety, comfort and peace of mind during MRI examinations,” says Alexander Hofer, Corporate Director of Product Management at MED-EL. “We take care of our users for a lifetime and they should have the opportunity to make use of everything modern medicine has to offer. This is especially important when diagnosing serious illnesses such as cancer, tumours, multiple sclerosis or Parkinson’s disease,” stresses Alexander Hofer.

Being able to undergo magnetic resonance imaging immediately can also be crucial in emergencies such as an accident. A further benefit: people with severe hearing loss only have to go without their ability to hear during the MRI examination itself.

Innovative technology excludes complications

The safe and reliable technology from MED-EL ensures that the magnets in place during the magnetic resonance imaging are neither damaged, nor dislocate causing pain. Only the external components, such as the audio processor, must be removed prior to the MRI examination.

“MED-EL has developed its own highly innovative, patented cochlear implant system with state-of-the-art implant magnets and their fixation within the implant. This excludes, for example, a dislocation of the magnet during an MRI scan, which can be very painful for the patient,” says Martin Zimmerling, Head of Implant Development at MED-EL. “With the SYNCHRONY cochlear implants,* the magnet can freely rotate and align according to the magnetic field of the MRI scan. With the altered implant design, undesirable forces during the MRI scan and the associated pain for the patient are reliably prevented,” explains Martin Zimmerling. “We are proud not only that the latest generation of our cochlear implants is compatible with MRI machines, but that all cochlear implants produced since 1994 are too, as well as all bone conduction implants from MED-EL.”

The increasing significance of magnetic resonance imaging makes it clear how important it is to provide people with severe hearing loss access to this gentle and high-resolution imaging process. MED-EL rises to this responsibility and provides extra security and comfort for all users with the MRI Guarantee.

 

About MED-EL 

MED-EL Medical Electronics, a leader in implantable hearing solutions, is driven by a mission to overcome hearing loss as a barrier to communication. The Austrian-based, privately owned business was co-founded by industry pioneers Ingeborg and Erwin Hochmair, whose ground-breaking research led to the development of the world’s first micro-electronic multi-channel cochlear implant (CI), which was successfully implanted in 1977 and was the basis for what is known as the modern CI today. This laid the foundation for the successful growth of the company in 1990, when they hired their first employees. To date, MED-EL has grown to more than 2,200 employees from around 75 nations and has 30 locations worldwide.
 
The company offers the widest range of implantable and non-implantable solutions to treat all types of hearing loss, enabling people in 124 countries enjoy the gift of hearing with the help of a MED-EL device. MED-EL’s hearing solutions include cochlear implant systems, a combined Electric Acoustic Stimulation hearing implant system, as well as surgical and non-surgical bone conduction devices. More than 95% of the hearing implants are exported and used by more than 4.000 clinics around the world. www.medel.com 
 

MED-EL Elektromedizinische Geräte Gesellschaft m.b.H.
Fürstenweg 77a
6020 Innsbruck, Austria
CEO Doz. DI Dr DDr med. h.c. Ingeborg Hochmair

 

Press contact:

PR & Corp Communications Team
T: +43 5 7788-0 

 

*MED-EL cochlear implants since 1994 are MR Conditional. Recipients with a MED-EL cochlear implant may be safely MRI scanned following the conditions detailed in the Medical Procedures Manual.
1Unless required for diagnostic reasons. So as to avoid imaging difficulties in the immediate vicinity of the implant, it may be advisable to remove the magnets.
2The terms and conditions of the MRI guarantee can be found at https://go.medel.com/mri-guarantee-terms.
3Source: OECD. Magnetic resonance imaging exams 2016–2019..

 

Icon_ContactPress Contact

T: 704-341-1544
E: media.us@medel.com
www.medel.com